Baek‐Yeol Ryoo
Ulsan College(KR)Asan Medical Center(KR)University of Ulsan(KR)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial(2019)1,782 cited
- → Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial(2015)838 cited
- → Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma(2022)590 cited
- → Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study(2020)559 cited
- → Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial(2022)504 cited